Head of Commercialization & Analytics
|Joseph B. Musumeci
Head of Operations
|Casey Cormier is one of the industry’s pioneering developers of “bottom-up” payer account-level forecasting methodologies. As Head of the Data Analytics Program, she ensures that all SkyLaunch tools are continually equipped with the most advanced payer access analytics and forecasting methodologies.
Prior to integrating SkyLaunch’s forecasting platform, Ms. Cormier served as the Principal of the Data Analytics Group at Insight Strategy Advisors, where she constructed payer account-level forecasts and models across a variety of products and therapeutic areas in the U.S. market. Before joining Insight, she worked in payer/provider strategy with Accenture’s Health & Life Sciences Division. Prior to working at Accenture, she spent time on the clinical side as a Circulatory Support Technician at California Pacific Medical Center in San Francisco.
Ms. Cormier holds a Bachelor of Arts in Biochemistry from Harvard University.
|Joe Musumeci brings his background in managed markets, product pricing, and launch forecasting to the continued refinement of SkyLaunch’s cutting-edge launch forecasting tools. Prior to building SkyLaunch’s payer access platform, he worked in managed markets consulting for Insight Strategy Advisors, where he managed pharma/biotech initiatives across therapeutic areas including CV/Metabolic, Oncology, Respiratory, GI, CNS, Infectious Disease and Pain Management. His focus has been the U.S. market, but he has also led projects to support 5EU/BRICT pricing, access and launch initiatives.
Mr. Musumeci also spent additional time working in pharma through his experiences with oncology product development at Eisai Pharmaceuticals, as well as at Vantage Partners, a consulting firm with a robust pharma/biotech practice. Finally, he also formerly worked in mergers & acquisitions investment banking, and in private equity with Harris Williams & Co. and Wells Fargo, respectively.
Mr. Musumeci holds a Bachelor of Arts in Biology with a focus on Biochemistry from Harvard University.